Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Nov 05, 2023  5 months, 3 weeks, 1 day, 11 hours, 18 minutes ago

COVID-19 News: German Study Shows That SARS-CoV-2 Particles Promote Airway Epithelial Differentiation And Ciliation

1375 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
COVID-19 News: German Study Shows That SARS-CoV-2 Particles Promote Airway Epithelial Differentiation And Ciliation
Nikhil Prasad  Fact checked by:Thailand Medical News Nov 05, 2023  5 months, 3 weeks, 1 day, 11 hours, 18 minutes ago
COVID-19 News: The COVID-19 pandemic, triggered by the Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), has had far-reaching implications for global public health. This novel coronavirus enters the human body primarily through the respiratory tract's epithelial cells. The airway epithelium plays a crucial role in trapping and eliminating pathogens via a process known as mucociliary clearance, involving ciliated and secretory cells. These cells produce mucus, which captures pathogens and foreign particles and is subsequently expelled from the respiratory system.


Schematic overview of the tri-culture airway model and its differentiation. Created with BioRender. (B) PAS reaction of a histological section of a typical tri-culture model. (C) Prototypic SEM image of the differentiated tri-culture model epithelium. (D) Typical immunofluorescence staining of pan-cytokeratin (green), cell nuclei (DAPI), and CD31 (red) within tri-culture models. Scale bars: 100 µm (B,D), 20 µm (C).

This COVID-19 News report covers a recent study conducted by researchers from RWTH Aachen University, the University of Duisburg-Essen, University Medical Center Essen-Ruhrlandklinik, and the Center for Molecular Biology of Heidelberg University in Germany that has shed light on the early interactions between SARS-CoV-2 particles and the airway epithelium. Using advanced 3D airway tri-culture models exposed to ultraviolet (UV)-irradiated virus particles, they explored the impact of SARS-CoV-2 on the differentiation of airway epithelial cells.
 
Results
The study unveiled several noteworthy findings:
 
-Airway Tri-Cultures as a Valuable Model: The researchers employed a 3D airway tri-culture model to mimic the human airway. This model includes human endothelial cells, human tracheal mesenchymal cells, and mucociliated human tracheal epithelial cells embedded in a fibrin hydrogel matrix. This model effectively simulates the interactions of respiratory epithelial cells with SARS-CoV-2.
 
-Increased Ciliation in Response to SARS-CoV-2 Particles: Exposure to inactivated SARS-CoV-2 particles led to a significant increase in ciliation on the epithelial surface. This was a surprising finding, as previous research had primarily focused on the loss of ciliated cells caused by replicating SARS-CoV-2.
 
-Cellular Responses: The study also revealed that contact with SARS-CoV-2 particles resulted in a loss of cell-cell tight junctions and impaired the barrier integrity of the airway epithelium.
 
-FOXJ1 and PAK1/2 Involvement: Further immunofluorescence analyses indicated an increase in FOXJ1 expression, a transcription factor essential for the formation of motile cilia. This observation suggested a connection between viral particle-induced ciliation and FOXJ1 induction. Additionally, the activation of p21-activated kinases (PAK1/2) by phosphorylation was associated with the observed ciliation response.
  /> Discussion
This study's findings have significant implications for understanding the interaction between SARS-CoV-2 particles and the respiratory epithelium, offering valuable insights into the early stages of virus invasion.
 
Ciliary Response to SARS-CoV-2: The research challenges previous assumptions about the loss of ciliated cells during SARS-CoV-2 infection. While replicating virus reduces ciliation over time, this study demonstrates that exposure to inactivated SARS-CoV-2 particles stimulates an increase in cilia. This novel finding raises questions about the viral determinants and cellular factors that drive this response.
 
Potential Ciliation-Inducing Factors: The study suggests that SARS-CoV-2 particles may carry a viral factor that induces ciliation, even in the absence of viral replication. Understanding the nature of this factor and its role in the ciliation response is an avenue for future research.
 
Transient Increase in FOXJ1 Expression: The transient increase in FOXJ1 expression following exposure to SARS-CoV-2 particles indicates a rapid cellular response to the virus. Further investigation is needed to uncover the precise mechanisms and signaling pathways involved in this response.
 
Balance Between Cell Types: The study also highlights the potential impact on the balance between different cell types in the respiratory epithelium. The differentiation of club cells into ciliated cells may have consequences for the secretion of protective proteins, which could impact the overall function and barrier integrity of the airway.
 
Barrier Integrity: The observed changes in the distribution of claudin-1, a component of tight junctions, may suggest alterations in the airway's barrier function. While this study did not directly measure barrier integrity, the findings hint at potential consequences for the airway's ability to prevent pathogen invasion.
 
Future Directions and Implications
This research underscores the complexity of the interaction between SARS-CoV-2 particles and the airway epithelium. It opens up various avenues for further investigation:
 
-In Vivo Studies: While this study provides valuable insights into the early stages of virus interaction with airway epithelial cells, in vivo studies are necessary to validate these findings and provide a more comprehensive understanding of the processes at play.
 
-Long-Term Effects: It is essential to explore the long-term effects of the observed compensatory ciliation response. This will help determine whether it has a protective or detrimental role in the pathogenesis of respiratory infections.
 
-Immune Response: Future research should incorporate immune cells, such as macrophages and neutrophils, to better understand the immune response to inactivated SARS-CoV-2 particles and its impact on the airway epithelium.
 
-Clinical Implications: Understanding the interplay between SARS-CoV-2 particles and airway epithelial cells could have clinical implications. It may inform strategies for preventing and treating respiratory viral infections and respiratory diseases involving ciliary dysfunction.
 
-Ciliary Regeneration: The ability to stimulate the regeneration of cilia in the respiratory epithelium could hold promise for treating conditions like primary ciliary dyskinesia. However, interventions must carefully balance ciliary regeneration with maintaining epithelial barrier integrity.
 
In conclusion, this German study provides crucial insights into the early interactions between SARS-CoV-2 particles and the airway epithelium. It challenges previous assumptions, shedding light on the dynamic response of airway cells to viral particles. Further research is needed to explore the broader implications of these findings and their potential for improving our understanding of respiratory infections and diseases.
 
The study findings were published in the peer reviewed journal: Frontiers in Bioengineering and Biotechnology.
https://www.frontiersin.org/articles/10.3389/fbioe.2023.1268782/full
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.

MOST READ

Jun 10, 2023  11 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  2 years ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19